/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | PBHPrestige Consumer He |
|---|---|
| Last close | $42.98close 2026-11-06 |
| Change % | -3.02%close 2026-11-06 |
| Market cap | $2.0Bclose 2026-11-06 |
| P/E | 11.0FY to 2026-03-31 |
| Revenue | $1.1B⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldRevenueFromContractWithCustomerExcludingAssessedTax |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice.
| Rev growth (YoY) | -4.3%FY to 2026-03-31 |
| Net income | $190M⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofFY ending 2026-03-31 FilingDEF 14A · 0001295947-26-000021 · filed 2026-06-29 Open the filing on EDGAR →Open the XBRL payload →CitePrestige Consumer Healthcare Inc. (PBH), us-gaap:NetIncomeLoss: 190,300,000 USD, fiscal year ended 2026-03-31. Form DEF 14A, accession 0001295947-26-000021, filed 2026-06-29. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001295947/us-gaap/NetIncomeLoss.json |
| Net margin | 17.5%FY to 2026-03-31 |
| EPS (diluted) | $3.91⊙EVIDENCE — filed/published fact SourceSEC XBRL companyfacts FieldEarningsPerShareDiluted As ofFY ending 2026-03-31 Filing10-K · 0001295947-26-000016 · filed 2026-05-14 Open the filing on EDGAR →Open the XBRL payload →CitePrestige Consumer Healthcare Inc. (PBH), us-gaap:EarningsPerShareDiluted: 3.91 USD per share, fiscal year ended 2026-03-31. Form 10-K, accession 0001295947-26-000016, filed 2026-05-14. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0001295947/us-gaap/EarningsPerShareDiluted.json |
| Piotroski F-ScoreUNVALIDATED | 3FY to 2026-03-31 |
| Altman Z-ScoreUNVALIDATED | 2.17FY to 2026-03-31 |
| Beneish M-ScoreUNVALIDATED | inputs not filed |
| Next earnings | 01-30 → 02-09 |